Literature DB >> 20530984

Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty.

B Predieri1, S Luisi, E Casarosa, E Farinelli, F Antoniazzi, M Wasniewska, S Bernasconi, F Petraglia, L Iughetti.   

Abstract

BACKGROUND: Allopregnanolone, a neuroactive steroid mainly secreted by adrenals and gonads, is a hormone that seems to play a role in precocious puberty, as demonstrated by its high baseline levels found in girls with central precocious puberty (CPP). Allopregnanolone concentrations significantly increase after GnRH and ACTH stimulation test suggesting both its ovarian and adrenal production. AIM: Aim of this study was to evaluate allopregnanolone concentrations after GnRH and GnRH agonist analog stimulation test in girls with CPP to better establish its secretion source. SUBJECTS AND METHODS: Gonadotropins and steroid hormones were evaluated in different days after GnRH and triptorelin stimulation test in 15 CPP girls.
RESULTS: After GnRH stimulation, LH, FSH, and allopregnanolone concentrations significantly increased (p<0.05). After triptorelin administration LH, FSH, estradiol and DHEAS levels significantly increased (p<0.05), while allopregnanolone concentrations significantly decreased (1.08±0.24 vs 0.87±0.28 nmol/l; p=0.003).
CONCLUSIONS: The different response of allopregnanolone to GnRH and GnRH agonist analog might reflect the agonist and antagonist action exerted by these secretagogues. Our data suggest the prevalent gonadal allopregnanolone production in CPP subjects and the usefulness of its measurement in the diagnosis of CPP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530984     DOI: 10.1007/BF03346693

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  36 in total

1.  Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.

Authors:  T Uemura; T Yanagisawa; K Shirasu; A Matsuyama; H Minaguchi
Journal:  Am J Obstet Gynecol       Date:  1992-07       Impact factor: 8.661

2.  Paradoxical ovarian stimulations in the use of LHRH analogs.

Authors:  J Parinaud; P Oustry; I Bussenot; A Tourre; M Perineau; M Plantavid; X Monrozies; J M Reme; G Pontonnier
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1992-11-19       Impact factor: 2.435

3.  Variations in pattern of pubertal changes in girls.

Authors:  W A Marshall; J M Tanner
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

4.  Cellular mechanism of the angtigonadotropic action of luteinizing hormone-releasing hormone in the corpus luteum.

Authors:  H R Behrman; S L Preston; A K Hall
Journal:  Endocrinology       Date:  1980-09       Impact factor: 4.736

5.  Gonadotrophin-releasing hormone and triptorelin inhibit the follicle stimulating hormone-induced response in human primary cultured granulosa-lutein cells.

Authors:  C Furger; N Bourrié; L Cedard; F Ferré; J R Zorn
Journal:  Mol Hum Reprod       Date:  1996-04       Impact factor: 4.025

6.  Interaction of prostaglandin F2alpha and gonadotropin-releasing hormone on progesterone and estradiol production in human granulosa-luteal cells.

Authors:  J E Väänänen; B L Tong; C M Väänänen; I H Chan; B H Yuen; P C Leung
Journal:  Biol Reprod       Date:  1997-12       Impact factor: 4.285

7.  Multiple inhibitory actions of luteinizing hormone-releasing hormone agonist on luteinizing hormone/human chorionic gonadotropin receptor-mediated ovarian responses.

Authors:  P V Reddy; S Azhar; K M Menon
Journal:  Endocrinology       Date:  1980-10       Impact factor: 4.736

8.  The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.

Authors:  L R Garibaldi; T Aceto; C Weber; S Pang
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

Review 9.  Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.

Authors:  R Rupprecht
Journal:  Psychoneuroendocrinology       Date:  2003-02       Impact factor: 4.905

10.  Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.

Authors:  Sigrid Nyberg; Torbjörn Bäckström; Elisabeth Zingmark; Robert H Purdy; Inger Sundström Poromaa
Journal:  Gynecol Endocrinol       Date:  2007-05       Impact factor: 2.260

View more
  2 in total

1.  Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test.

Authors:  Robert L Rosenfield; Brian Bordini; Christine Yu
Journal:  J Clin Endocrinol Metab       Date:  2013-03-01       Impact factor: 5.958

2.  Contemporary issues in precocious puberty.

Authors:  Anurag Bajpai; P S N Menon
Journal:  Indian J Endocrinol Metab       Date:  2011-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.